PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+9.84%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$4.03B
AUM Growth
+$621M
(+18%)
Cap. Flow
+$84M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
32.52%
Holding
106
New
17
Increased
37
Reduced
18
Closed
19
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$126M |
| 2 |
Centene
CNC
|
$85.6M |
| 3 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$79.2M |
| 4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$59.9M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$58.1M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$313M |
| 2 |
Universal Health Services
UHS
|
$91.1M |
| 3 |
Pacira BioSciences
PCRX
|
$87.8M |
| 4 |
McKesson
MCK
|
$72.1M |
| 5 |
Alibaba
BABA
|
$58.5M |
Sector Composition
| 1 | Healthcare | 41.83% |
| 2 | Technology | 15.77% |
| 3 | Communication Services | 6.66% |
| 4 | Consumer Discretionary | 5.76% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
UnitedHealth
UNH
$281B
| $59.7M | 1.17% |
305,072
-23,757
| -7% | -$4.65M |
|
|
27
SPDR S&P 500 ETF Trust
SPY
$662B
| $58.1M | 1.14% |
+231,451
| New | +$58.1M |
|
28
Box
BOX
$4.74B
| $56M | 1.1% |
2,896,214
+1,642,335
| +131% | +$31.7M |
|
|
MDCO
29
DELISTED
Medicines Co
MDCO
| $55.6M | 1.09% |
1,501,003
-311,999
| -17% | -$11.6M |
|
30
Pfizer
PFE
$140B
| $54.6M | 1.07% |
+1,613,081
| New | +$54.6M |
|
31
Penumbra
PEN
$10.9B
| $53.3M | 1.05% |
590,673
+163,668
| +38% | +$14.8M |
|
32
Molina Healthcare
MOH
$9.26B
| $49.2M | 0.97% |
716,094
-164,308
| -19% | -$11.3M |
|
33
Netflix
NFLX
$534B
| $49.1M | 0.97% |
+270,929
| New | +$49.1M |
|
34
Humana
HUM
$37.5B
| $49M | 0.96% |
201,190
-135,117
| -40% | -$32.9M |
|
35
PayPal
PYPL
$65.4B
| $48.1M | 0.95% |
751,075
+375,676
| +100% | +$24.1M |
|
36
Revvity
RVTY
$9.95B
| $46.5M | 0.91% |
674,267
+85,727
| +15% | +$5.91M |
|
37
DXC Technology
DXC
$2.6B
| $40.2M | 0.79% |
541,424
-362,428
| -40% | -$26.9M |
|
38
SPDR S&P Biotech ETF
XBI
$5.28B
| $39.9M | 0.78% |
+461,125
| New | +$39.9M |
|
39
Palo Alto Networks
PANW
$129B
| $38.5M | 0.76% |
1,604,994
| – | – |
|
40
Evolent Health
EVH
$1.1B
| $36.7M | 0.72% |
2,063,033
+1,614,855
| +360% | +$28.7M |
|
41
Kura Oncology
KURA
$706M
| $36.1M | 0.71% |
2,411,552
+374,059
| +18% | +$5.59M |
|
|
SNNA
42
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $35.2M | 0.69% |
+1,580,410
| New | +$35.2M |
|
43
S&P Global
SPGI
$165B
| $34.9M | 0.69% |
223,475
-35,174
| -14% | -$5.5M |
|
44
NetEase
NTES
$84.3B
| $34.3M | 0.67% |
649,935
+151,555
| +30% | +$8M |
|
45
Icon
ICLR
$13.7B
| $32.3M | 0.63% |
283,195
+63,005
| +29% | +$7.17M |
|
46
Merit Medical Systems
MMSI
$5.46B
| $30M | 0.59% |
707,440
+322,539
| +84% | +$13.7M |
|
|
ELGX
47
DELISTED
Endologix Inc
ELGX
| $29.7M | 0.58% |
665,898
+105,951
| +19% | +$4.73M |
|
|
ZEN
48
DELISTED
ZENDESK INC
ZEN
| $28.6M | 0.56% |
981,832
+431,300
| +78% | +$12.6M |
|
49
Esperion Therapeutics
ESPR
$510M
| $27.5M | 0.54% |
548,682
+334,702
| +156% | +$16.8M |
|
|
JNCE
50
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $26.9M | 0.53% |
1,727,997
+1,029,838
| +148% | +$16M |
|